DexCom (DXCM) Revenue — Quarter Ended Jun 30, 2023
The reporting period posted a higher revenue compared to the immediately prior quarter. Revenue also increased relative to the same quarter one year earlier.
Key takeaway
Quarter ended Jun 30, 2023 · FY2023 Q2
The reporting period posted a higher revenue compared to the immediately prior quarter. Revenue also increased relative to the same quarter one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$871.3M
Revenue reported for this quarter.
Quarter-over-quarter
+17.5%
Change from the immediately preceding quarter.
Year-over-year
+25.2%
Change from the comparable year-ago quarter.
Trailing four quarters
$3.2B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2022 | $769.6M | +18.4% |
| Dec 31, 2022 | $815.2M | +16.8% |
| Mar 31, 2023 | $741.5M | +17.9% |
| Jun 30, 2023 | $871.3M | +25.2% |
Revenue performance
Revenue rose from the preceding quarter, continuing an upward trajectory observed in recent periods. The year-over-year comparison also showed a gain, reinforcing the positive direction.
Quarterly comparison
Compared with the immediately preceding quarter, revenue improved. The same quarter one year earlier also reported a lower revenue figure, underscoring sustained growth.
What to watch
Given the sequential and annual comparisons both point upward, monitoring whether the pace of change sustains in future quarters may be worth attention.